The write up draws attention to AMS' wound closure products in the context of a possible war with Iraq. It also says that AMS now concentrates on the hospital and nursing home markets because they pay more for bigger and more complex dressings, compared with the consumer who generated nearly half Group sales up to 1998. It also states that the global wound care market is now worth $10 billion.
It highlights the acquisition of MedLogic and the synergy with AMS especially with MedLogic's tissue adhesive and tissue barrier products, and states that AMS is close to being profit making.
It indicates that a broker, Baird, is forecasting a £200,000 profit for 2002 and £1.3m in 2003, with tax losses available to shelter profits for some years.
It highlights the Group development of herbal agents including tea tree oil and aloe vera and their incorporation into bandages and plasters because of the benefits derived from moist dressings in accelerating healing and reducing pain and suggests the first silver based products, currently in development, will be launched in 2003.
It also highlights the quality of the top 8 clients, which account for 80% of sales. These include Johnson & Johnson and Smith & Nephew.
It suggests the share price could reach 12p.
I hope this helps.
American Shared Hospital Services Stock Charts :
American Shared Hospital Services Historic Stock Chart
American Shared Hospital Services Intraday Stock Chart
American Shared Hospital Services stock quotes
American Shared Hospital Services stock charts
Follow this thread
